CAR-T: Advancing the Path for Clinical and Commercial Success 

The Prescient team has prepared a white paper discussing our view on the recent advances in the CAR-T landscape. Industry and academia appear to be making significant strides in simplifying manufacturing and administration processes, expanding clinical utility and enabling access for patients.

Complete the form to request the white paper and learn about the progress being made to overcome clinical and commercial hurdles in the CAR-T space.

By: Ben Doran, Stuart Crichton, Ben Druck and Vasiliki Patsioura

Ben_Stuart CAR-T

Request our White Paper via Email